Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01014572 · ClinicalTrials.gov registry record · Phase 2
The Effect of Exercise and Alagebrium on the Diastolic Function of the Heart
A Phase 2 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 62
- Enrollment target
NCT01014572 is a Phase 2 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 62 participants.
The verdict
NCT01014572, a Phase 2 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 62 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether an investigational drug (Alagebrium (generic: ALT-711), a type of medication referred to as an advanced glycaton end-product clever) can be combined with exercise training to reverse the stiffening of the heart that takes place naturally with aging.
Interventions
- BEHAVIORAL Aerobic Exercise Training
- DRUG Alagebrium (generic: ALT-711)
- BEHAVIORAL Tai Chi and/or Yoga Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2008-07 |
| Est. Completion | 2013-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01014572
The ClinicalTrials.gov registry entry for NCT01014572 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Aerobic Exercise Training is the first listed.
NCT01014572 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01014572 about?
NCT01014572 is a clinical study titled "The Effect of Exercise and Alagebrium on the Diastolic Function of the Heart". The purpose of this study is to determine whether an investigational drug (Alagebrium (generic: ALT-711), a type of medication referred to as an advanced glycaton end-product clever) can be combined with exercise training to reverse the stiffening of the heart that takes place naturally with aging.
What is the current status of trial NCT01014572?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 62 participants. The study started on 2008-07. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01014572?
The interventions under investigation include: Aerobic Exercise Training (BEHAVIORAL), Alagebrium (generic: ALT-711) (DRUG), Tai Chi and/or Yoga Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT01014572?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.